INTRODUCTION
Reversible protein phosphorylation is an essential regulatory mechanism in many cellular processes. In general, cells use this post-translational modification to alter the properties (activity, localization, etc.) of key regulatory proteins involved in specific pathways. While in the past much attention has been paid to the regulation of protein kinases, it is now apparent that protein phosphatases (PPases) -like the kinases -are highly regulated enzymes that play an equally important role in the control of protein phosphorylation. This review focuses on the structure, regulation and biological role of protein phosphatase type 2A (PP2A), a major serine\threonine PPase in eukaryotic cells.
STRUCTURE OF PP2A
Several holoenzyme complexes of PP2A have been isolated from a variety of tissues and have been extensively characterized. The core enzyme is a dimer (PP2A D ), consisting of a 36 kDa catalytic subunit (PP2A C ) and a regulatory subunit of molecular mass Abbreviations used : AKAP, muscle A-kinase anchor protein ; AP-1, activator protein-1 ; APC, adenomatous polyposis coli protein ; CAK, Cdkactivating kinase ; CAPP, ceramide-activated protein phosphatase ; Cdk, cyclin-dependent kinase ; CG-NAP, centrosome-and Golgi-localized protein kinase N-associated protein ; CREB, cAMP regulatory element binding protein ; Dsh, Dishevelled ; 4E-BP1, eukaryotic initiation factor 4E binding protein 1 ; eRF, eukaryotic release factor ; ERK, extracellular-signal-regulated kinase ; GSK, glycogen synthase kinase ; HEAT, huntingtin/elongation/A subunit/TOR ; HSF, heat-shock transcription factor ; I 1 PP2A and I 2 PP2A , inhibitors of PP2A ; IκB, inhibitor of nuclear factor-κB ; JAK2, Janus kinase 2 ; LCMT, leucine carboxyl methyltransferase ; Lef, lymphoid enhancer binding factor ; MAPK, mitogen-activated protein kinase ; MEK, MAPK/ERK kinase ; MPF, M-phase-promoting factor ; (m)TOR, (mammalian) target of rapamycin ; NF-κB, nuclear factor-κB ; OA, okadaic acid ; PAK, p21-activated kinase ; PHAP, putative histocompatibility leucocyte antigen class II-associated protein ; PKA, protein kinase A ; PKB, protein kinase B ; PKC, protein kinase C ; PKR, double-stranded RNA-dependent kinase ; Plx1, polo-like kinase ; PME-1, PP2A methylesterase 1 ; PP2A, protein phosphatase type 2A ; PP2A C , catalytic subunit of PP2A ; PP2A D , dimeric form of PP2A ; PPase, protein phosphatase ; PTPase, phosphotyrosine phosphatase ; PTPA, PTPase activator ; RTS1, rox three suppressor 1 ; SCR, sex combs reduced ; SET, Suvar3-9, enhancer of zeste, trithorax ; SG2NA, S/G 2 nuclear autoantigen ; SIT4, suppressor of His4 transcription 4 ; SV40, simian virus 40 ; Tap, two A phosphatase-associated protein ; TCF, T-cell factor ; TGF-β, transforming growth factor-β ; TNFα, tumour necrosis factor α ; TPD3, tRNA production defect ; TRIP-1, TGF-β receptor II interacting protein 1 ; YY1, Yin Yang 1. 1 To whom correspondence should be addressed (e-mail jozef.goris!med.kuleuven.ac.be).
The regulatory A subunit (PR65)
The A subunit is a structural subunit that is tightly associated with PP2A C , forming a scaffold to which the appropriate B subunit can bind. Different B subunits interact via the same or overlapping sites within the A subunit of the core dimer, which explains why binding of the B subunits is mutually exclusive [22, 23] .
As is the case for the catalytic subunit, in Mammalia two distinct PR65 isoforms are present, α and β, which share 86 % sequence identity ; both are ubiquitously expressed [24] . In general, PR65β appears to be much less abundant than PR65α, except in Xenopus oocytes [25] . In the latter, the PR65β mRNA is highly expressed in the ovary during oogenesis, meiotic maturation and fertilization, up to stage 35 of embryogenesis. From that stage on, the β\α ratio starts to decrease gradually [26] . Interestingly, PR65β has been identified as a putative human tumour suppressor [27, 28] . Somatic alterations in the gene encoding PR65β were discovered in 15 % of primary lung and colon tumour-derived cell lines. These alterations, including entire gene deletions, internal and C-terminal protein deletions, and missense and frame shift mutations, are likely to disrupt the structure of the core PP2A heterodimer. More recently, in the gene encoding the PR65α isoform, mutations were detected in human melanomas and breast and lung carcinomas, albeit with lower frequency when compared with the PR65β studies [29] . Aberrant levels of A\PR65 may severely compromise the functional activity of PP2A to regulate the cell cycle (see below), a notion supported by the finding that rat fibroblasts overexpressing PR65α, become multinucleated [30] .
The structure of PR65 is unusual, since it is entirely composed of 15 tandem repeats of a 39-amino-acid sequence, termed a HEAT (huntingtin\elongation\A subunit\TOR, where TOR is target of rapamycin) motif. Tandem repeats of HEAT motifs are found in a variety of proteins (reviewed in [31] ), including the huntingtin protein, an elongation factor required for protein synthesis and the TOR kinase. The crystal structure of PR65α [32] revealed that the fundamental architecture of each repeat is virtually the same, being composed of two superimposed α-helices. The particular stacking of these repeats within the PR65 molecule gives rise to a stable protein with an overall asymmetrical and elongated architecture, reminiscent of a hook (Cshape). The evolutionarily conserved PR65 residues and the exposed hydrophobic surfaces are localized to the intra-repeat turns, connecting the two helices of each HEAT motif, and are likely to constitute the sites of interaction with the catalytic subunit and the B subunits. As such, the structural data seem to confirm the biochemical data obtained from reconstitution experiments with wild-type and mutated PP2A subunits [22, 23, 33] . Similarly, the Lys%"' Glu substitution, known to reduce the affinity between PR65 and PP2A C by 100-fold [34] , could be rationalized by the structural data [32] .
The regulatory B subunits
Two striking features of the B subunits are their diversity, stemming from the existence of entire subunit families, and the total lack of sequence similarity between these gene families, even though they recognize similar segments of the A subunit.
B or PR55 family
In Mammalia, the 55 kDa subunit is encoded by four genes (PR55α, PR55β, PR55γ and PR55δ), which are expressed in a tissue-specific manner [35] [36] [37] [38] : PR55α and PR55δ have a widespread tissue distribution, whereas PR55β and PR55γ are highly enriched in brain. Analysis of the spatial and temporal expression patterns of PR55α, PR55β and PR55γ in the brain revealed that levels of PR55α are high in striatum, those of PR55γ are high in hindbrain, and those of PR55β are low in cerebellum [39] . PR55α and PR55β also have distinct localization patterns within neurons : PR55α is distributed primarily in the cell body and nucleus of Purkinje cells, whereas PR55β is excluded from the nucleus and extends into dendrites. PR55α and PR55β are mainly cytosolic, and PR55γ is enriched in the cytoskeletal fraction. In contrast with PR55α, PR55β and PR55γ are developmentally regulated, with PR55β levels decreasing and PR55γ levels increasing sharply after birth [39] . As the A and C subunits are present uniformly, these data indicate that the B subunits confer subcellular localization, developmental regulation and cell specificity to the PP2A holoenzyme in brain. Recently, in subjects with spinocerebellar ataxia (a neurodegenerative disorder), an expanded CAG repeat has been identified immediately upstream of the PR55β gene (extending into the 5h untranslated region) that might affect PR55β expression and might be implicated in the aetiology of the disease [40] .
A structural feature of the PR55 subunits is the presence of five degenerate WD-40 repeats [41] . WD-40 repeats are minimally conserved sequences of approx. 40 amino acids that typically end in tryptophan-aspartate (WD) and are thought to mediate protein-protein interactions (reviewed in [41] ). In this respect, PR55α and PR55β have been shown to interact with the cytoplasmic domain of kinase-active type I transforming growth factor-β (TGF-β) receptors and to be a direct target for their kinase activity [42] . Previously it had been demonstrated that TGF-β receptor II interacting protein-1 (TRIP-1), a protein largely composed of WD-40 repeats, can associate with the closely related type II TGF-β receptors [43] , thereby suggesting that binding of both PR55 and TRIP-1 to the TGF-β receptors could be mediated by their WD-40 repeats.
Bh or PR61 family
The Bh family contains at least five distinct gene products, denoted α, β, γ, δ and ε [44] [45] [46] [47] [48] [49] [50] , which have been localized to human chromosomes 1q41, 11q12, 3p21, 6p21.1 and 7p11.2-p12 respectively [51] . The human Bhβ gene encodes two isoforms, β1 and β2. At least three different splice variants exist of the human Bhγ form (γ1, γ2 and γ3 ; in addition, γ4 and γ5 may be predicted from rabbit cDNA sequences [45] ). All Bh family members contain a highly conserved central region (80 % identical), while both the C-and N-termini are significantly more divergent. This suggests that the conserved region is required for interaction with the A and possibly the C subunit, whereas the ends may perform different functions, such as regulation of substrate specificity and subcellular targeting. Specifically, PR61α, PR61β and PR61ε localize to the cytoplasm, whereas PR61γ1, PR61γ2 and PR61γ3 are concentrated in the nucleus, and PR61δ is found in both the nucleus and the cytoplasm. Moreover, all isoforms except one (PR61γ1) are phosphoproteins [48] . PR61δ, for instance, which was purified initially from human erythrocytes [52] , can be phosphorylated in itro by protein kinase A (PKA) [52, 53] (see  below) .
Northern analyses indicate tissue-specific expression of the isoforms. PR61α and PR61γ1-γ3 are widely expressed, and are extremely abundant in heart and skeletal muscle [44, 46] . PR61β and PR61δ are expressed predominantly in brain [44, 45] . Interestingly, upon retinoic acid-induced differentiation of neuroblastoma cells, the expression of the brain-specific PR61β and PR61δ forms increases, whereas the isoforms that are less abundant in brain show a slight or no increase in expression [48] . This suggests that the expression of PR61β and PR61δ may be developmentally regulated in the brain.
Bd or PR72 family
A trimeric PP2A holoenzyme containing the PR72 subunit was purified from rabbit skeletal muscle and its third subunit cloned from a human heart muscle library [54] . A related clone, PR130, was isolated from a human brain library and contains a different N-terminus. It was suggested that PR72 and PR130 might arise from the same gene by alternative splicing. PR72 is expressed exclusively in heart and skeletal muscle, whereas PR130 was detected in almost all tissues analysed, but with highest levels in heart and muscle [54] .
Recently, two new members of the Bd family were identified by a yeast two-hybrid screen approach. PR59 shares 56 % identity and 65 % similarity with PR72, and was identified as an interaction partner of the retinoblastoma-related p107 protein [55] . Its expression pattern differs completely from that of PR72, being detected in testis, kidney, liver, brain, heart and lung, but not in skeletal muscle. Interestingly, overexpression of PR59 results in inhibition of cell cycle progression and accumulation of cells in G " . This phenomenon is probably related to an increase in the amount of hypophosphorylated -and thus active -p107 that was observed when PR59 and p107 were co-expressed.
PR48 shares 68 % homology with PR59, and was identified as an interaction partner of Cdc6, a protein required for the initiation of DNA replication [56] . PR48 localizes to the nucleus, and Cdc6 seems to be a selective substrate for the PR48-containing PP2A trimer. As with PR59, overexpression of PR48 causes a G " arrest. It is believed that PP2A keeps Cdc6 in the dephosphorylated form, a prerequisite for binding to origins of DNA replication.
Be or PR93/PR110 family
Based on a conserved epitope, shared with the Bh subunits, striatin (PR110) and S\G # nuclear autoantigen (SG2NA ; PR93) were identified as new members of a potential Be subunit family [57] . Like the B\PR55 family, striatin and SG2NA contain WD-40 repeats and interact with PP2A D . Both proteins also bind to calmodulin in a calcium-dependent manner. Striatin is localized to the post-synaptic densities of neuronal dendrites, whereas SG2NA is nuclear. Striatin-PP2A D and SG2NA-PP2A D complexes contain several additional unidentified proteins, suggesting that striatin and SG2NA may function as scaffolding proteins involved in Ca# + -dependent signalling [57] .
REGULATION OF PP2A

Holoenzyme composition
Although there are only two C subunit isoforms of PP2A, the number of potential combinatorial associations of the different A and B\Bh\Bd\Be regulatory subunits is very large. Given the occurrence of two A, two C, four B, at least eight Bh, four Bd and two Be isoforms, a total of about 75 different dimeric and trimeric PP2A holoenzymes can be generated. This specific holoenzyme composition provides many possibilities for regulation. First, due to their specific cellular and subcellular localizations, the third subunits can target the PPase to different tissues and cellular compartments. Secondly, the presence of different regulatory subunits has been shown to determine the substrate specificity of PP2A holoenzymes in itro [58] [59] [60] [61] [62] [63] [64] , and probably also in i o. For instance, the presence of PR55 is a prerequisite for PP2A to efficiently dephosphorylate the intermediate filament protein vimentin in itro and in situ [65] . In addition, PR55-containing trimers can efficiently dephosphorylate substrates phosphorylated by p34 cdc# kinase [62, 64] . Thirdly, the presence or absence of additional subunits can modulate the response to agents that modify PP2A activity in itro (such as protamine and heparin) [34, 66] , and affects the catalytic activity of PP2A towards the same substrate. For instance, the C subunit as such is more active towards phosphoprotein substrates than is the core enzyme (PP2A D ) in itro [34] , whereas the reverse is true for activity towards phosphopeptides [60] . On the other hand, in the presence of polycations, A\PR65 stimulates PP2A C activity towards phosphoproteins [34] , whereas polycations are without effect on PP2A D activity towards phosphopeptides [60] . Similarly, the B subunits also modulate the catalytic activity of PP2A D , suppressing activity towards some substrates, but greatly enhancing the dephosphorylation of others [52, 58, 59, 61, 62, 67, 68] .
Post-translational modifications
Phosphorylation
In itro, the catalytic subunit of PP2A can be phosphorylated by the tyrosine kinases pp60 v-src , pp56 lck , and the epidermal growth factor and insulin receptors [69] . The phosphorylation occurs on Tyr$!(, which is located in the conserved C-terminal part of PP2A C , and results in inactivation of the enzyme. Tyrosine phosphorylation of PP2A C is enhanced in the presence of the phosphatase inhibitor okadaic acid (OA), suggesting that, under normal conditions, PP2A can rapidly re-activate itself in an autodephosphorylation reaction. This observation has the important implication that PP2A can also act as a phosphotyrosine phosphatase (PTPase) (see below). In i o, tyrosine phosphorylation of PP2A C was detected in a small PP2A fraction recovered from activated human T cells, and in fibroblasts overexpressing pp60 v-src [70] . Moreover, growth stimulation of cells in response to epidermal growth factor or serum [71] , in response to interleukin-1 or tumour necrosis factor α (TNFα) [72] , or in response to insulin [73] [74] [75] also promoted a transient tyrosine phosphorylation and inactivation of PP2A. Thus the increased phosphorylation of PP2A in intact cells by growth factors and cell transformation implies in i o regulation of PP2A. Moreover, the concomitant transient inactivation of PP2A could be an accelerating factor during the transmission of signals through kinase cascades. This attractive model places PP2A in a pivotal position to modulate signal transduction cascades.
In addition to phosphorylation on Tyr$!(, PP2A C can also be phosphorylated in itro on threonine(s) by an autophosphorylation-activated protein kinase [76] . The precise location of the Thr phosphorylation site(s) remains to be determined. Interestingly, this phosphorylation leads to the inactivation of both the phosphoserine\threonine [76] and the phosphotyrosine PPase activities of PP2A [77] . In this case also, PP2A can reactivate itself by autodephosphorylation. The physiological implications of the inactivation of PP2A by threonine phosphorylation remain elusive.
Not only is PP2A C subject to phosphorylation, but also the regulatory B subunits -notably those of the Bh family -can be phosphorylated. Phosphorylation of PR61δ might regulate PP2A activity in i o, since phosphorylation of PR61δ by PKA in itro changes the substrate specificity of the trimeric enzyme, without dissociating the Bh subunit from PP2A [53] . More recently, the double-stranded-RNA-dependent protein kinase (PKR) was shown to interact with and phosphorylate PR61α, both in itro and in i o [78] . Phosphorylation of PR61α by PKR increased the activity of the ABhαC trimer towards protein kinase C (PKC)-phosphorylated myelin basic protein and PKR-phosphorylated eukaryotic translation initiation factor 2α in itro. Indirect evidence was obtained to confirm this PKR-mediated alteration of PP2A activity in i o [78] .
Methylation
All PP2A C sequences identified to date have a T$!%PDYFL$!* motif at their C-terminus. This motif not only contains Tyr$!(, but is also the recognition site for carboxymethylation by a specific carboxyl methyltransferase [79] [80] [81] . Methylation occurs on the carboxy group of the C-terminal residue Leu$!* and is reversible in i o, due to the presence of a specific methylesterase [82, 83] . OA inhibits methylation of PP2A [84, 85] , probably by binding to the C-terminus and thereby preventing access of the transferase to its target site. In Xenopus oocyte extracts, cAMP moderately stimulates PP2A methylation, whereas Ca# + and calmodulin have no effect [85] . In contrast with these observations, it was reported that, in rat pancreatic cells, Ca# + stimulated methylation and cAMP had no influence [86] . Interestingly, methylation of PP2A C varies during the cell cycle. In general, PP2A C is methylated throughout the cycle, but temporary decreases in methylation are observed at the G ! \G " boundary in the cytoplasm, and at the G " \S boundary in the nucleus [87] . The mechanism and the physiological consequences of this oscillating methylation are unknown.
The human methyltransferase and methylesterase have recently been cloned. LCMT-I (leucine carboxyl methyltransferase-I) was purified from porcine brain, and the human homologue was cloned based on tryptic peptides from the porcine form [88] . Database screening revealed the existence of a putative homologue with a long C-terminal extension (LCMT-II) containing five Kelch-like repeats, but it remains to be determined whether this protein actually possesses methyltransferase activity towards PP2A [88] . PME-1 (PP2A methylesterase-1) was identified as a protein that associated specifically with two catalytically inactive mutants of PP2A [89] . Like PP2A C , PME-1 is highly expressed in brain and testis.
Conflicting data exist with regard to the effect of PP2A C methylation on its catalytic activity, with one group observing a moderate increase in phosphatase activity [90] , another seeing no direct effect on phosphatase activity [88] , and a third observing a decrease in activity [91] . Therefore it is believed that methylation of PP2A C may affect other characteristics of PP2A. In this respect it was demonstrated that, in order for the B\PR55α subunit to bind, not only do the seven C-terminal residues of PP2A C have to be intact [92] , but also the C-terminal Leu$!* residue has to be methylated [93] . Moreover, PP2A D , as isolated from tissues, was found to be fully demethylated [88, 93] , whereas trimers containing Be\striatin\SG2NA [57] or Bd\PR72 [88] were fully methylated, and trimers containing B\PR55 were sometimes methylated and sometimes not [88] . Taken together, the reversible carboxymethylation of PP2A C may affect the holoenzyme composition of PP2A. In i o evidence for this hypothesis is provided by a transient and reversible interconversion of holoenzyme forms (from a Bh-containing trimer to a B-containing trimer) during the initial stage of retinoic acidinduced granulocytic differentiation, which coincides with increased methylation of PP2A C [91] . However, whether the increased methylation of PP2A C is the consequence rather than the cause of this interconversion remains to be determined. Moreover, disruption of the Saccharomyces cere isiae homologue of LCMT-I (but not LCMT-II) results in decreased methylation of PPH21 (one of the budding-yeast homologues of PP2A C ) and in decreased binding of TPD3 (tRNA production defect 3 ; a PR65 homologue), Cdc55 (a PR55 homologue) and, to a lesser extent, RTS1 (rox three suppressor 1 ; a PR61 homologue) [94] . This suggests that, in yeast, methylation of PPH21 is important for the formation of trimeric and dimeric PP2A complexes in i o.
Second messengers : activation of PP2A by ceramide
In many signalling pathways, one of the early intracellular biochemical responses to extracellular stimulation is the generation of lipid-like second messengers, such as ceramide. Depending on the cell type, ceramide can induce differentiation, cell Structure, function and regulation of protein phosphatase 2A proliferation, growth arrest, inflammation or apoptosis (reviewed in [95, 96] ). A number of direct cellular targets for ceramide have been identified, including a ceramide-activated protein kinase, a ceramide-activated protein phosphatase (CAPP) and PKCζ [95, 96] .
CAPP was initially identified as a cytosolic PPase that was cation-independent and inhibited by OA [97] . Later studies identified the enzyme as a type 2A PPase [98] . Ceramide activation of PP2A was initially reported to require the presence of the B subunit [98] , but a more recent study has indicated that ceramide is also able to activate PP2A D and the catalytic subunit alone [99] . Purification and characterization of CAPP from rat brain revealed that it is composed predominantly of ABC and ABhC, as well as AC complexes [100] . The role of PP2A as a ceramide effector is conserved in yeast [101] . In mammalian cells, some downstream targets of CAPP include c-myc, Bcl2 and c-Jun. In HL-60 cells, activation of the TNFα receptor results in the generation of ceramide, down-regulation of c-myc and eventually apoptosis. Since OA inhibits these effects, it was suggested that CAPP activity is important for the ceramide-induced downregulation of c-myc in these leukaemia cell lines [102] . Moreover, in these cells, ceramide was found to specifically activate a mitochondrial PP2A, which rapidly and completely induced the dephosphorylation and inactivation of Bcl2, a potent antiapoptotic protein [103] . Further, in TNFα-treated A431 cells, rapid hydrolysis of sphingomyelin was accompanied by c-Jun dephosphorylation ; OA inhibited this effect [104] . Moreover, a partially purified CAPP preparation could dephosphorylate cJun in itro, suggesting that it may be a direct substrate of CAPP in i o.
Inhibitory proteins
Two specific, non-competitive and heat-stable inhibitors of PP2A were purified from bovine kidney and termed, by analogy with the PP-1-specific inhibitors, I " PP#A and I # PP#A [105] . Both proteins inhibit all holoenzyme forms of PP2A, probably by binding directly to the catalytic subunit. In intact cells, overexpression of I # PP#A results in increased expression, DNA-binding and Ser'$ phosphorylation of c-Jun, and in higher transcriptional activity of activator protein-1 (AP-1) [106] . These effects are reversed by overexpression of haemagglutinin-tagged PP2A C , consistent with I # PP#A acting as a PP2A inhibitor in i o. Interestingly, in the presence of near-physiological concentrations of Mn# + , I " PP#A and I # PP#A also associate with and markedly stimulate the activity of PP-1 towards some substrates, whereas Mn# + does not affect the inhibition of PP2A by I " PP#A and I # PP#A [107] . This might suggest a novel role for I " PP#A and I # PP#A in the co-ordination of PP-1 and PP2A activities within cells.
Based on some amino acid sequences, I " PP#A was identified as PHAP-I (putative histocompatibility leucocyte antigen class IIassociated protein-I) [108] and I # PP#A as a truncated cytoplasmic form of PHAP-II, also termed SET (Suvar3-9, enhancer of zeste, trithorax) or TAF-Iβ (template-activating factor-Iβ) [109] . SET, in its complete form, is a nuclear protein and contains an additional highly acidic C-terminal region that is involved in chromatin remodelling. SET itself is also a potent and specific inhibitor of PP2A [109] , and exerts its inhibitory activity via its N-terminal part [110] . SET is phosphorylated in i o on two serine residues, probably by PKC [111] . Interestingly, in acute non-lymphocytic myeloid leukaemia, SET is found to be fused to CAN (nucleoporin Nup214), apparently as a result of a chromosomal translocation [112] . As such, the formation of this SET-CAN fusion protein may impair the normal regulation of PP2A and contribute to leukaemogenesis. In this respect, it was also shown that HRX leukaemic fusion proteins (resulting from another common genetic alteration in human acute leukaemia) associate with SET and co-immunoprecipitate PP2A [113] , suggesting that HRX fusion proteins may function in conjunction with SET and PP2A to de-regulate cell growth.
Modulation of the levels of expression of PP2A and its subunits
Although expression of PP2A C is tightly controlled by an autoregulatory translational mechanism [21] , there are some reports describing changes in PP2A C levels, for instance during all-trans-retinoic acid-induced differentiation of HL-60 cells [114, 115] , during adipocyte differentiation induced by peroxisome proliferator-activated receptor-γ [116] , and in macrophages stimulated by colony-stimulating factor 1 [117] . Also, the expression of some of the PP2A subunits is developmentally regulated [26, 39, 48] . The underlying mechanisms for these differences in regulation of expression remain unknown.
PP2A as a PTPase
It has long been known that, apart from their apparent phosphoserine\threonine PPase activity, PP2A enzymes also exhibit low but detectable PTPase activity in itro [118, 119] . This PTPase activity can be regulated independently from the Ser\Thr PPase activity. The characterization in itro of the ' dual specificity ' of PP2A indicates that the phosphoserine and phosphotyrosine PPase activities exhibit distinct catalytic properties and thermostability [118, 119] . They are either conversely affected by free ATP or pyrophosphate [120, 121] , or stimulated concurrently by tubulin [122] . A third regulatory mechanism for the PTPase activity of PP2A involves a specific protein factor, the PTPase activator (PTPA).
A few years ago the PTPA protein was isolated from rabbit skeletal muscle, Xenopus lae is oocytes, dog liver, pig brain and budding yeast [4, [123] [124] [125] [126] . PTPA specifically stimulates the PTPase activity of the dimeric form of PP2A, and to a lesser extent that of the free catalytic subunit, without affecting the serine\threonine PPase activity. The PTPase activity of the trimeric ABdC and ABC enzymes is not, or is much less, affected by PTPA. The exact activation mechanism is currently unclear, but requires the presence of physiological concentrations of ATP\Mg# + . The latter might suggest that PTPA is a kinase, but this possibility could be excluded, due to (1) the lack of phosphate incorporation into either PP2A D or PTPA itself, (2) the lack of kinase activity ascribable to PTPA using exogenous substrates, and (3) the lack of a canonical kinase motif in the primary PTPA sequence. The low ATPase activity detected appeared to be a consequence rather than a direct cause of the activation [123, 127] . In contrast with the basal, ATP-stimulated and tubulin-stimulated PTPase activity, which remains stable over a long period of time, the PTPA-induced PTPase activity of PP2A D is transient, and decreases rapidly during phosphotyrosine hydrolysis. It seems that PTPA induces a reversible conformational change in PP2A, so that the same catalytic site becomes accessible by the larger tyrosine phosphate [4] . In this respect, a weak interaction between PP2A and PTPA has been observed [123] .
The possible relevant physiological role played by PTPA is suggested by : (1) its cellular concentration, which is sufficiently high (micromolar) to play an important role in the regulation of PP2A, (2) the specific substrate specificity of PTPA-stimulated PP2A, which differs from that of the authentic PTPases in itro [128] , and (3) its ubiquity and abundance in differentiated and proliferating tissues, in organisms ranging from yeast to humans [123] . The molecular cloning of PTPA from rabbit and human has revealed 96.6 % identity within their primary structures [126] . PTPA homologues have been found in Xenopus, Drosophila, Saccharomyces cere isiae and Schizosaccharomyces pombe [124] . From an alignment of these various PTPA cDNAs, some highly conserved ' boxes ' of amino acids can be determined, which appear to be essential for PTPA activity. Interestingly, one of these boxes contains the consensus motif for a type B ATPbinding site, which could explain the ATP-dependence of PTPA activity [124] .
Human PTPA is encoded by a single gene that has been mapped to chromosome 9q34 [129] and gives rise to seven alternatively spliced transcripts (PTPAα-PTPAη), four of which encode functional proteins [130] . A classical promoter analysis revealed that basal expression of the gene requires the activity of the ubiquitous transcription factor Yin Yang 1 (YY1), which positively regulates basal promoter activity through binding to two functional cis elements in the minimal promoter [131] . Interestingly, the tumour suppressor protein p53 can significantly down-regulate PTPA expression, both in normal conditions and in conditions where p53 is activated by UVB irradiation. This p53-mediated suppression occurs through an as yet unknown mechanism involving the negative control of YY1 [132] .
So far, information on the role of PTPA in i o comes solely from studies applying molecular genetics in yeast. In Saccharomyces cere isiae, PTPA is encoded by two genes, YPA1 and YPA2. Deletion of both genes is lethal [133, 134] , but this lethality can be rescued by overexpression of PPH22, one of the yeast homologues of PP2A C [134] . In general, single disruption of YPA1 results in a more severe phenotype than single disruption of YPA2 [133,134,134a] , suggesting that the two proteins are not completely redundant. The phenotype of single YPA1 mutants is pleiotropic and resembles the phenotype of PP2A-deficient strains in specific aspects, such as aberrant bud morphology, abnormal actin distribution and similar growth defects in various growth conditions [134a] . YPA1 mutants are also defective in at least two mitogen-activated protein kinase (MAPK) pathways (the osmosensing or HOG1 pathway, and the PKC\MPK1 pathway) [134] and progress more rapidly to S-phase after G " -arrest [133] . Additional data on the role of YPA1 in i o came from a report by Ramotar et al. [135] , who showed that YPA1 mutants display hypersensitivity to oxidative DNA damage. This implies a function for PTPA in the pathway(s) signalling the repair or in the repair itself of this type of DNA damage. The authors suggest that these effects occur independently of PP2A, but the data provided to sustain this claim are debatable. Finally, YPA1 mutants are rapamycin-resistant [133, 134] , suggesting that PTPA may be implicated in the TOR pathway (see below).
Although a genetic interaction is observed between YPA and PPH, and although yeast PTPA stimulates the PTPase activity of rabbit PP2A D in itro, the effect of yeast PTPA on yeast PP2A is less clear. Moreover, tyrosine phosphorylation is a rare event in yeast. This could indicate that PTPA might affect other characteristics of PP2A. In this respect, it has been shown that a YPA1 deletion strain contains much more trimeric ABC PP2A than a wild-type strain, which contains much more of the dimeric AC form [134a] . Thus it is possible that PTPA may affect the subunit composition of PP2A, not favouring association of the dimer with a third subunit. Another interesting observation came from the discovery of an inactive PP2A fraction that can be isolated during the purification of PP2A holoenzymes from rabbit skeletal muscle or pig brain (J. Goris, unpublished work). For unknown reasons, this inactive form is always found in association with PME-1, but, more importantly, its serine\ threonine PPase activity can be completely restored by the addition of PTPA. Since it is obvious that inactivation and reactivation of PP2A could be an important event in i o (occurring for instance during the cell cycle ; see below), PTPA may be an important player in this equilibrium.
BIOLOGICAL ROLE OF PP2A Use of specific, cell-permeable phosphatase inhibitors
The discovery of many naturally occurring phosphatase inhibitors, which are able to penetrate living cells, has been a breakthrough in the study of the functions of PPases in i o. The best studied, and most widely used, of these is OA, a polyether fatty acid produced by marine dinoflagellates and the causative agent of diarrhoetic shellfish poisoning [136] . OA inhibits the serine\threonine PPases to differing extents : PP2A is inhibited most strongly (K i 0.2 nM), followed by PP-1 (K i 2 nM) ; PP2B is even less sensitive (K i 10 µM) and PP2C is not inhibited at all [137] . In addition to these four major PPases, PP4\PPX [138, 139] and PP5 [140] were shown to be almost as sensitive to OA as PP2A, whereas PP7 is completely insensitive [141] . Interestingly, the PTPase activity of PP2A is also potently inhibited by OA, with the K i values lying in the same nanomolar range [142, 143] . Since this activity is relatively insensitive to vanadate, a potent inhibitor of the classical PTPases, this criterion can help to distinguish PP2A PTPase activity from other cellular PTPases.
In spite of these different sensitivities, care has to be taken when using OA to discriminate between the activities attributable to the actions of various PPases in i o. Indeed, OA does not penetrate cell membranes rapidly, but accumulates slowly, making it difficult to control the actual concentration of the compound in i o. Also, the efflux of OA can vary considerably between different cell lines [144] . Moreover, the amount of OA needed to inhibit specific PPases depends on the concentration of the PPases within the cell. Since, for instance, the cellular concentration of PP2A is estimated to be in the micromolar range [145] , complete inhibition may only be achieved with relatively high concentrations of OA, and these concentrations may also affect the activities of PPases, which are less sensitive to OA, but which are present at lower cellular concentrations. Nevertheless, conditions for the selective inhibition of PP2A in intact cells, which take into account the penetration kinetics, have been established [146] . Moreover, in cell-free extracts, the former limitations do not exist, and OA is a valuable tool for distinguishing between different PPases acting upon a given substrate.
With regard to its mechanism of action, OA has been shown to bind directly to the catalytic subunits of PP2A and PP-1, albeit with different affinities [147] . Resistance to OA in Chinese hamster ovary cells has been associated with a more rapid efflux of OA, and with a Cys#'* Gly mutation in the C-terminal region of PP2A C α [144] . This cysteine residue is conserved in OA-sensitive PPases (PP2A and PP4), but not in PP-1 and PP2B. Moreover, substitution of residues 274-277 (Gly-Glu-Phe-Asp) of PP-1 C with the corresponding PP2A C α residues 267-270 (Tyr-Arg-CysGly) results in a chimaeric mutant that shows a 10-fold increase in OA-sensitivity, indicating that this region may determine the specificity of the PPase-OA interaction [147] .
OA induces various biological effects in i o, including promotion of tumour growth in mouse skin [148] , stomach and liver [149] , prolonged smooth muscle contraction [150] and promotion of genomic instability [151] [152] [153] . Intriguingly, in some systems OA promotes malignant transformation [154] , whereas in others it inhibits transformation and induction of cell growth [155] [156] [157] , and promotes differentiation [158] . Despite the diversity of these effects, all are likely to result from the de-regulation of OAsensitive PPases. Structure, function and regulation of protein phosphatase 2A Following these studies on OA, several other PPase-inhibiting compounds have been identified, including calyculin A [159] , microcystin-LR [160] , tautomycin [161] , nodularin [162] , cantharidin [163] , and their respective derivatives. The K i values of these inhibitors are similar for PP-1 and PP2A, with the exceptions of cantharidin, which, like OA, can be used to distinguish between PP2A (IC &! 0.16 µM) and PP-1 (IC &! 1.7 µM), and of tautomycin, which is more specific for PP-1 [149] .
PP2A and the cell cycle : an OA-sensitive phosphatase negatively regulates entry into mitosis
At present, one of the best-documented cyclin-dependent kinase (Cdk)-cyclin complexes is MPF (M-phase-promoting factor), which consists of the p34 cdc# kinase (Cdc2 or Cdk1) and cyclin B, and is involved in the G # \M transition (see [164] for a review). In G # , Cdc2 associates with freshly synthesized cyclin B and is phosphorylated on three sites (Figure 2 ) : Thr"'" is phosphorylated by CAK (Cdk-activating kinase), which itself consists of Cdk7 and cyclin H ; Thr"% is phosphorylated by the dualspecificity kinase Myt1 ; and Tyr"& becomes phosphorylated by the Wee1 kinase and\or by Myt1. This triple-phosphorylated complex is inactive and is called pre-MPF. Final activation of pre-MPF occurs when the inhibitory Thr"% and Tyr"& are dephosphorylated by the dual-specificity PPase Cdc25, the activity of which, in its turn, is regulated positively by phosphorylation ( Figure 2 ). MPF phosphorylates specific substrates, such as histone H1, lamins, vimentin, cyclins and microtubuleassociated proteins, explaining the initiation of mitotic processes such as nuclear breakdown, chromosome condensation and spindle formation. At the end of mitosis, MPF is inactivated by cyclin B destruction and by dephosphorylation of Thr"'". The exit from mitosis is also promoted by dephosphorylation of MPF substrates [164] (Figure 2) .
The implication of PP2A in the regulation of the G # \M transition was initially suggested through experiments using OA. Injection of OA into Xenopus [142, 165] or starfish [166] oocytes induces the formation of active MPF, resulting in meiotic maturation. In starfish oocytes, activation of MPF requires a nuclear component that inhibits PP2A, and which can be bypassed by addition of OA [167] . OA, but not the PP-1 inhibitors I-1 and I-2, induces Cdc2 kinase activation in interphase extracts [168] . Similarly, OA treatment of BHK21 cells synchronized early in S-phase results in the induction of mitosis-specific events and in a significant rise in Cdc2 kinase activity towards histone H1 [169] . Together, these data suggest that PP2A is required to maintain MPF in its inactive precursor form. INH, originally identified as an activity that could inhibit activation of pre-MPF, was indeed shown to be a form of PP2A [170] , more particularly a trimer containing the Bα\PR55 subunit [171] . In itro, PP2A can dephosphorylate a specific site on Cdc2 [170] , later identified as Thr"'" [172] , resulting in Cdc2 inactivation. Subsequently it was found that PP2A inhibits the pathway leading to phosphorylation of Thr"'", rather than being involved in the direct dephosphorylation of Thr"'" [171] . PP2A may therefore play a role in the control of CAK activity, since CAK is the kinase responsible for Thr"'" phosphorylation. Furthermore, genetic evidence indicates that PP2A may also positively regulate the activity of the Wee1 kinase, responsible for the inhibitory Tyr"& phosphorylation, possibly by direct dephosphorylation of Wee1 [173] . In contrast, PP2A can dephosphorylate Thr"% in itro without dephosphorylating Tyr"&, even in the presence of PTPA, leading to a partial activation of Cdc2 [174] . This observation could be part of an explanation for a sequential dephosphorylation of Thr"% and Tyr"& by PP2A and Cdc25 respectively. However, dephosphorylation of Cdc2 by Cdc25 in itro also occurs successively (first Thr"%, then Tyr"&), as observed in i o during starfish oocyte maturation [174] . Moreover, in the presence of vitamin K3, an inhibitor of Cdc25, the two inhibitory sites on Cdc2 remain phosphorylated and activation of Cdc2 is prevented [174] . Taken together, the observations with OA [165] [166] [167] [168] [169] 
Another factor contributing to the negative effect of PP2A on the G # \M transition is situated at the level of Cdc25, the activity of which is required for dephosphorylation of the inhibitory Thr"% and Tyr"& sites on Cdc2 in the Cdc2-cyclin B complex (Figure 2) . At a certain threshold of cyclin B, Cdc25 is activated through phosphorylation. This is followed by a positive-feedback loop between Cdc2 and Cdc25 : Cdc25 activates Cdc2, and Cdc2 in turn contributes to the further phosphorylation and activation of Cdc25. This mechanism explains the rapid activation of MPF, preceding M-phase (reviewed in [164] ). A major question is how this positive-feedback loop is initially triggered. Karaı$ skou et al. [175, 176] provide evidence that MPF auto-amplification depends upon a two-step mechanism. In a first step, Cdc25 activates Cdc2 with linear kinetics, and no auto-amplification takes place. In G # , an unknown inhibitory factor is present (PP2A could be excluded) that prevents the phosphorylation and activation of Cdc25. Therefore the precise trigger of this first activation step remains elusive. In a second step, a polo-like kinase (Plx1) catalyses the hyperphosphorylation of Cdc25. Interestingly, this step occurs in itro only when PP2A is inhibited by OA. This shows that PP2A antagonizes the action of Plx1, and strongly suggests that PP2A is the physiological PPase that catalyses the dephosphorylation of the Plx1-phosphorylated residues of Cdc25. This is in line with the previous observation that, in itro, PP2A can dephosphorylate the hyperphosphorylated form of Cdc25, keeping it in a low-activity state [177] . Finally, PP2A, together with PP-1, may also be implicated in the exit from mitosis, since cyclin degradation and the subsequent inactivation of MPF at the metaphase\anaphase transition are affected by an OA-sensitive PPase [168, 169] . In support of this, Vandre! and Wills [178] showed that low OA concentrations result in a metaphase-like mitotic block of a pig kidney cell line, suggesting the involvement of PP2A in the transition from metaphase to anaphase. Moreover, maintenance of cyclin B destruction during G " requires the activity of a PP2A-like PPase, since OA, but not I-2, blocked destruction of cyclin B in G " extracts [179] . In addition, PP2A (more specifically, the trimeric ABC complex) seems to be the major enzyme that dephosphorylates several physiological substrates of p34 cdc# [62, 64] , such as histone H1 [62, 64, 180] , the high-mobility group protein I(Y) [180] , caldesmon [64, 180] , vimentin [65] and the cis-Golgi matrix protein GM130 [181] .
The regulatory functions of PP2A at the G # \M transition are summarized in Figure 2 . However, it is clear that, in order to fulfil these functions, the activity of PP2A has to be tightly regulated as well. In particular, for progression into mitosis PP2A has to be inactivated, and at the exit from mitosis it has to be re-activated. Intriguingly, both the expression and the activity of PP2A were found to be constant throughout the cell cycle when using phosphorylated myosin light chains as a substrate [182] . In contrast, the microtubule-associated PP2A pool is regulated during the cell cycle [183] , as is the methylation state of PP2A [87] . However, in both cases the underlying mechanisms that affect the activity of PP2A remain to be elucidated.
Use of molecular genetics
Yeast
The biological role of PP2A in Saccharomyces cere isiae and Schizosaccharomyces pombe has been investigated extensively by genetic analyses of deletion mutants of the different PP2A subunits, with the exception of the Bd subunits (of which no yeast homologues seem to exist) (reviewed in [184] ). Recently it was demonstrated that the ' yeast system ' can also be very useful for the identification of catalytically impaired and dominant-negative mutants of human [185] [186] [187] and Arabidopsis [186] PP2A C . The direct use of these mutants in human or Arabidopsis cells is likely to be a useful tool with which to study the biological role of PP2A in the future.
In Schiz. pombe, PP2A C is encoded by two genes, ppa1 and ppa2, and their double disruption is lethal [17] . In contrast with the single ppa1 disruption, the single ppa2 disruption results in a particular phenotype : ppa1 + ppa2 − cells exhibit retarded growth and decreased cell size, indicating premature entry into mitosis. This observation suggests that ppa1 represents a minor fraction of the PP2A activity in the cell and only partially substitutes for ppa2 [17] . The effects of ppa2 disruption on cell size and growth can be mimicked by OA [173] . Apparently, ppa2 interacts genetically with the cell cycle regulators cdc25 and wee1: ppa2∆ can suppress the cdc25-22 mutation, but is lethal in combination with the wee1-50 mutation, indicating that, in fission yeast, PP2A is a negative regulator of the G # \M transition, interacting with the machinery involved in Cdc2 activation [173] . Thus these data confirm results obtained in higher eukaryotes.
In Sacch. cere isiae the situation is slightly different. PP2A C is encoded by two genes, PPH21 and PPH22, which are linked genetically and encode polypeptides that share 74 % amino acid sequence identity with mammalian PP2A [18] . Disruption of either PPH gene alone is without any major effect, but the double disruption causes a very severe growth defect and is lethal in the absence of PPH3, a related PPase gene [18, 188] . Thus, in this case, both gene products perform essential cellular functions that are largely or even completely overlapping. pph21\pph22 mutants have a highly abnormal morphology, with cells and buds being shrunken and pear-shaped, possibly resulting from de-regulation of the cytoskeleton [188] . The generation of yeast strains expressing temperature-sensitive forms of PPH21 [189] or PPH22 [190] , in a genetic background where the other PPH gene is deleted, has yielded further evidence for roles of PP2A in morphogenesis and mitosis. In either case, bud morphology was perturbed at the restrictive temperature, resulting from a disturbed organization of the actin cytoskeleton. Another defect in these strains is blockage of the cells in G # , due to : (1) the fact that the mitotic spindles are not able to form or not able to extend, and (2) decreased activity of Cdc2\cyclin B, necessary for the advancement from G # into mitosis [189, 190] . Therefore these data suggest a positive role for PP2A in the G # \M transition, and as such oppose the data obtained in Schiz. pombe and in higher eukaryotes. The reason for this is still unclear.
In Sacch. cere isiae, the A\PR65 subunit is encoded by TPD3, a gene identified as being required for production of tRNA [191] . The tRNA production defect in tpd3 mutant strains could be overcome by the addition of TFIIIB (but not TFIIIC), despite normal levels of TFIIIB and RNA polymerase III in the mutant extracts [192] . The data suggest that dephosphorylation of some element of the transcriptional machinery by PP2A is important for regulating RNA polymerase III transcription. Another phenotype of these tpd3 mutant strains results from defects in cytokinesis, since most cells become multi-budded and multi-nucleated [192] . Similarly, disruption of the paa1 gene (encoding the Schiz. pombe homologue of PR65) causes anomalies in microtubule and actin distribution [193] .
Mutations in CDC55, encoding the Sacch. cere isiae B\PR55 homologue, result in highly elongated, multiply budded cells, indicative of delayed cytokinesis [36] . CDC55 has multiple roles in mitosis. cdc55 mutants are hypersensitive to nocodazole and thus lack a functional kinetochore\spindle assembly checkpoint, whereas their cell cycle progression in response to DNA damage or an inhibitor of DNA synthesis is not affected [194, 195] . The spindle assembly checkpoint contributes to the accuracy of mitosis by delaying the onset of anaphase until the spindle has been fully assembled and each pair of sister chromatids is attached to it. This defective spindle assembly checkpoint in cdc55 mutants allows inactivation of Cdc2-cyclin B by tyrosine phosphorylation (instead of cyclin B destruction) and sister chromatid separation in cells that lack spindles [194] . Similarly, in Schiz. pombe disruption of pab1 (encoding the PR55 homologue) causes reduced growth, morphological abnormalities (such as defects in cell wall synthesis, sporulation and cytoskeletal distribution) and delayed cytokinesis [193] .
RTS1, which encodes the Sacch. cere isiae homologue of the Bh\PR61 subunit family, was isolated independently by two laboratories, using different screening approaches. The first group isolated RTS1 as a multi-copy suppressor of a ROX3 mutation [196] . The ROX3 gene encodes an essential nuclear protein that functions in the global stress-response pathway. Deletion of RTS1 caused temperature and osmotic sensitivity [196] . The second group isolated RTS1\SCS1 as a high-copy suppressor of hsp60 ts mutant alleles. Disruption of RTS1 causes a reduction in the mRNA levels of the Hsp60 chaperonin and thus reduces the normal heat-shock response [197] . Therefore RTS1 plays a prominent role in the global stress response. Interestingly, a more recent paper showed that RTS1 is also required for the correct regulation of the cell cycle. N-terminally truncated forms of Rts1p lose this cell cycle regulatory capacity, while maintaining stress-related functions [198] . Moreover, it was shown that, with regard to this cell cycle-regulating ability, Rts1p and Cdc55p are functionally not interchangeable [198, 199] . In Schiz. pombe, two Bh\PR61 genes have been identified, par1 and par2 [200] . Neither gene is essential, but double-deletion mutants show abnormal septum positioning, anomalous cytokinesis and defects in growth under stressful conditions, very reminiscent of the ∆rts1 phenotypes in Sacch. cere isiae. Moreover, both genes can functionally complement RTS1 deletion in Sacch. cere isiae.
Drosophila
The molecular cloning of PP2A subunits from Drosophila melanogaster has provided additional insights into the role of PP2A in developmental processes, cell cycle regulation and intracellular signalling. To date, only PP2A C [14] , the A\PR65 [201] , the B\PR55 [202] and the Bh\PR61 [203] subunits have been cloned ; in contrast with the situation in yeast and Mammalia, each of them is encoded by a single gene. Moreover, a homologue of the Bd subunits is present in the Fly Base, but it has not yet been functionally characterized.
PP2A C is expressed throughout Drosophila development, but is notably much more abundant in early embryos [14] . PP2A C mutants die in embryogenesis around the time of cellularization, exhibiting overcondensed chromatin and a block in mitosis between prophase and the initiation of anaphase. The most striking feature of these PP2A C -negative embryos is that they possess multiple centrosomes with disorganized, elongated arrays of microtubules radiating from them in all directions, like a star [hence their name : microtubule star (mts) embryos] [204] . The data suggest that PP2A is required for the attachment of microtubules to chromosomal DNA at the kinetochore and the proper initiation of anaphase. Moreover, mutation of PP2A C affects the Ras1 signalling pathway controlling cell fate determination in the eye [205] . Ras1 and the downstream cytoplasmic kinases Raf, MEK (MAPK\ERK kinase, where ERK is extracellular-signal-regulated kinase) and MAPK comprise an evolutionarily conserved cascade that mediates the transmission of signals from receptors at the membrane to specific factors in the nucleus. A decrease in the dose of the gene encoding PP2A C stimulates signalling from Ras1, but impairs signalling from Raf. This suggests that PP2A regulates the Ras1 cascade both negatively and positively, by dephosphorylating factors that function at different steps in the cascade [205] .
Like PP2A C , A\PR65 is most abundant during early embryogenesis, and is expressed to a much lower extent in larvae and adult flies. Moreover, A\PR65 and PP2A C transcripts always colocalize. A\PR65 expression is high in oocytes, consistent with a high, equally distributed expression in early embryos. In later embryonic stages, expression remains high in the nervous system and the gonads, but the overall expression levels decrease. In third-instar larvae, high expression levels could be observed in brain, the imaginal discs and the salivary glands [201] . These results indicate that PP2A levels change during development in a tissue-and time-specific manner.
A cell cycle function of PP2A is again strongly suggested by the mitotic defects exhibited by two Drosophila mutants, termed aar1 (abnormal anaphase resolution) and twinsP, both of which are defective in the gene encoding B\PR55 (α and β). aar1 mutants typically display : (1) intact lagging chromatids that have undergone separation from their sisters, but which remain at the position formerly occupied by the metaphase plate ; and (2) anaphase figures that show bridging chromatin having two centromeric regions [206] . Apparently, these defects can be completely rescued by the re-introduction of intact B\PR55, but not of a truncated form lacking the C-terminal half of the B\PR55 coding region [202] . twinsP mutants typically contain morphologically abnormal imaginal discs : part of the wing imaginal disc is duplicated in a mirror-image fashion [207] . Since the differentiation fate of the cells comprising the disc is already so diversified as to produce an organ with a specific pattern, these data suggest that PP2A is crucial for the specification of tissue patterns. In both mutants, the reduced levels of B\PR55 correlate with reduced phosphatase activity towards p34 cdc# -phosphorylated substrates [64] . So far, these results, together with the previously described yeast data, suggest that PP2A not only is implicated in the negative regulation of mitosis, but also is involved in the control of structural events associated with mitosis. Also, it was shown in the Xenopus egg that PP2A is required to maintain the short-steady length of microtubules during mitosis, in part by regulating Op18\stathmin, a molecule involved in the control of microtubule dynamics [208] .
The Drosophila homologue of Bh\PR61 was picked up as a specific interaction partner of one of the Hox proteins, ' sex combs reduced ' (SCR) [203] . Interaction occurs with the Nterminal arm of the DNA-binding homeodomain that was shown to be a target of phosphorylation\dephosphorylation by PKA and PP2A. Dephosphorylation of this arm is required for SCR DNA binding in itro and for SCR activity in i o. Ablation of Bh\PR61 gene activity resulted in embryos without salivary glands, an SCR-null phenotype [203] . In another study, mammalian PP2A C α , β as well as PP-1 have been shown to interact with Hox11, another homeobox transcription factor controlling genesis of the spleen and possessing oncogenic properties [209] . In this case, interaction occurs via the N-terminus of Hox11 and does not involve the homeodomain. Moreover, Hox11 suppresses PP2A\PP-1 activity in itro and disrupts a G # \M cell cycle checkpoint in i o, since microinjection of Hox11 into Xenopus oocytes induces premature G # -to-M progression, and expression of Hox11 in Jurkat T cells abrogates γ-irradiation-induced G # arrest [209] .
Knock-out mice
To date, knock-out mice have only been established for the PP2A C α gene [210] . Mice lacking PP2A C α die around embryonic day 6.5, despite the fact that total levels of PP2A C are comparable with those in wild-type embryos. This indicates that PP2A C α and PP2A C β serve only partially redundant functions, since PP2A C β cannot completely compensate for the absence of PP2A C α . Degenerated embryos can be recovered even at embryonic day 13.5, indicating that, although embryonic tissue is still capable of proliferating, normal differentiation is significantly impaired. While the primary germ layers (ectoderm and endoderm) are present, mesoderm is not formed in degenerating embryos. The functional difference between PP2A C α and PP2A C β may be explained by their distinct subcellular localizations in the early embryo : while Cα was found predominantly in the plasma membrane, Cβ was localized mainly within the cytoplasm and the nucleus [211] . Moreover, at the plasma membrane, Cα forms a complex with E-cadherin and β-catenin, two components of the Wnt signalling cascade, which controls the epithelialmesenchymal transition during vertebrate development. In Cα −/− embryos, both E-cadherin and β-catenin are redistributed to the cytoplasm, resulting in degradation of β-catenin in both the presence and the absence of a Wnt signal [210, 211] .
Additional evidence implicating PP2A in Wnt signalling came from the observed association of PP2A C with axin, a binding protein for β-catenin and glycogen synthase kinase-3β (GSK-3β) [212] . Axin promotes the phosphorylation of β-catenin by GSK-3β, resulting in β-catenin degradation and inhibition of the Wnt pathway. In the presence of a Wnt signal, however, Dishevelled (Dsh) inhibits GSK-3β activation, and thus permits the accumulation of unphosphorylated β-catenin, which can translocate to the nucleus to transactivate the Wnt target genes in cooperation with Lef (lymphoid enhancer binding protein)\TCF (T-cell factor) transcription factors (reviewed in [213] ) (Figure 3) . Moreover, all Bh\PR61 isoforms interact with the adenomatous polyposis coli (APC) protein, which acts as a scaffolding protein for the assembly of β-catenin, axin and GSK-3β [214] . Axin also facilitates the GSK-3β-dependent phosphorylation of APC, and is itself also phosphorylated by GSK-3β [215, 216] . The direct binding of axin to APC enhances the phosphorylation of APC by GSK-3β, and the presence of β-catenin within the complex stimulates this reaction [217] . The axin-associated PP2A can directly dephosphorylate GSK-3β-phosphorylated APC and axin [217] . Overexpression of Bh\PR61 in mammalian cells [214] or co-injection of Bh\PR61ε and Dsh in early Xenopus embryos [218] reduces the level of β-catenin and inhibits β-cateninmediated transcription, suggesting a negative role for Bh\PR61 in the pathway upstream of or parallel to β-catenin phosphorylation. Bh\PR61 may directly inhibit PP2A C -mediated dephosphorylation of GSK-3β-phosphorylated APC, axin or β-catenin, or, alternatively, may negatively affect GSK-3β activity.
Another explanation for the Bh\PR61 overexpression effect could be the removal of ' active ' PP2A dimers or trimers other than ABhC out of the APC-GSK-3β-axin-β-catenin complex due to the artificial rise in Bh\PR61. Further, co-injection of PP2A C and Dsh in Xenopus embryos promotes Dsh-mediated signalling, whereas β-catenin stability is not affected [218] . This suggests an additional, positive role for PP2A C , downstream of β-catenin stabilization, which might be exerted at the level of Lef\TCF regulation in the nucleus [218] . The dual role of PP2A in Wnt signalling is summarized in Figure 3 .
The interaction of PP2A with viral proteins reveals its role in cell transformation
Cellular transformation by the small DNA tumour viruses simian virus 40 (SV40) and polyoma virus depends on the expression of the so-called tumour antigens, which form multiple complexes with cellular proteins involved in signal transduction and growth control, in order to change their normal functions. For instance, SV40 large T binds to the tumour suppressor proteins p53 [219] and Rb [220] , and thereby inactivates their function. Polyoma middle T forms large, multimeric complexes, in which it is associated with pp60 c-src [221] , with two other c-Src-like kinases (pp62 c-yes and pp59 c-fyn ) [222, 223] and\or with phosphatidylinositol 3-kinase [224] .
PP2A is another important cellular target for these viral antigens. Polyoma small t and middle T, as well as SV40 small t, form stable complexes with PP2A D by displacing the third subunit [225, 226] . PP2A is the only cellular protein known to bind to SV40 small t [225] . Only the free A\PR65 subunit and PP2A D , but not free C, can be complexed with small t, indicating that the PP2A-small-t interaction occurs via the A subunit [227] . The structural elements involved in this interaction have been determined [228] . Intriguingly, small t is able to replace the B\PR55 subunit, but not the Bh\PR61 subunit, from a trimeric PP2A complex [227, 229, 230] . In this respect, it has been shown that B\PR55 and the T antigens interact with overlapping HEAT repeats of A\PR65 [23] , suggesting that they may compete for the same binding sites on A\PR65.
The interaction of PP2A with SV40 small t alters the substrate specificity of PP2A D and inhibits PP2A D enzyme activity towards some substrates [227] . In contrast, complexes between PP2A and polyoma small t\middle T still display serine\threonine PPase activity [231] and, importantly, exhibit 10-fold elevated tyrosine PPase activity as compared with PP2A D [232] . This suggests that polyoma virus small t\middle T stabilizes the PTPase activity of PP2A in polyoma-virus-transformed cells in a PTPA-like fashion. A single point mutation in middle T, changing the conserved Cys"#! to Trp, abolishes interaction with PP2A, pp60 c-src and phosphatidylinositol 3-kinase, and abrogates cellular transformation [233] . Similarly, deletion of the cysteine-rich cluster harbouring Cys"#! in middle T, or of the corresponding region in small t, abolishes PP2A binding and the transforming ability of middle T [234] . In fact, all mutations that disrupt PP2A binding to middle T also disrupt the association between middle T and c-Src, making it likely that PP2A is required to recruit c-Src into the complex [234, 235] . PP2A activity seems not to be required for this recruiting ability, since catalytically inactive PP2A C mutants can still bind middle T and support complex-formation with pp60 c-src [236] .
Apparently the viral antigens, particularly SV40 small t, target PP2A to overcome its negative role in some signalling pathways leading to increased cell proliferation. It is in the interest of the virus to remove this block. When analysed in CV-1 cells, complexformation of PP2A with SV40 small t resulted in inhibition of Structure, function and regulation of protein phosphatase 2A
Figure 3 Role of PP2A in Wnt signalling
In the absence of a Wnt signal (left panel), β-catenin is present in two distinct complexes. One complex is located at the plasma membrane, where PP2A Cα stabilizes the β-catenin-E-cadherin complex, which itself mediates interactions with the actin cytoskeleton. The other complex is located in the cytoplasm and contains axin, APC, GSK-3β and PP2A (ABhCβ). Within this complex GSK-3β is thought to be constitutively active, resulting in the phosphorylation of β-catenin, APC and axin. In this case, the associated PP2A activity may not be high enough to counteract GSK-3β-mediated phosphorylation. This may be achieved by negative regulation of PP2A C activity by Bh/PR61 -hence the PP2A ABhC trimer is denoted ' inactive '. Phosphorylated β-catenin is unstable, becomes ubiquitinated and is eventually degraded by proteasomes. In the presence of a Wnt ligand (right panel), GSK-3β activity in the APC-β-catenin-axin-GSK-3β-PP2A complex is blocked by Dishevelled, resulting in the accumulation of unphosphorylated axin, APC and β-catenin. PP2A may contribute to this state by directly dephosphorylating APC and axin, and possibly β-catenin. This implies that PP2A should be activated -or, alternatively, that the Bh/PR61-mediated inhibition of PP2A C activity should be relieved. How exactly this is achieved is not clear. Unphosphorylated axin will be degraded specifically, leading to dissociation of unphosphorylated β-catenin from the complex and accumulation in the cytosol. After translocation to the nucleus, it can transactivate specific target genes. There is evidence that PP2A C may be involved in this part of the pathway as well, either in the translocation of β-catenin to the nucleus or in the regulation of Lef/TCF transcriptional activity by β-catenin.
PP2A-mediated dephosphorylation of MEK and ERK, and thus in receptor-independent activation of these two kinases. Importantly, small t stimulation of ERK and MEK activity is totally dependent on binding to PP2A [229] . The effects of small t on MAPK signalling depend on the cell type examined, since in REF52 cells no effect was observed on MAPK-induced AP-1 activity upon small t overexpression, unless small t was coexpressed with either ERK or MEK [237] . Another mechanism by which SV40 small t promotes cell growth and transformation is by stimulating PKCζ activity, resulting in MEK activation and nuclear factor-κB (NF-κB)-dependent transactivation. Following inhibition of PP2A, PKCζ and NF-κB apparently become constitutively active [238] . A third transcriptional target of small t (in addition to AP-1 and NF-κB) is CREB (cAMP regulatory element binding protein). Small t inhibits dephosphorylation of PKA-phosphorylated CREB and thereby stimulates CREBdependent transactivation [239] . Also, the ability of SV40 small t to activate AP-1-and CREB-regulated promoters (e.g. that of the cyclin D1 gene) has been genetically linked to its PP2A binding [240] . Finally, small t also induces transactivation of Sp1-responsive promoters through inhibition of PP2A activity [241] .
The role of polyoma small t and middle T in signalling is less clear. In any case, they appear to use PP2A differently : small t promotes cell cycle progression in a manner dependent on its binding to PP2A, whereas a middle T mutant that still binds PP2A is unable to promote cell proliferation [242] . This could indicate that, in the multimeric middle T complex, PP2A serves other functions (such as its formerly described tyrosine kinaserecruiting function).
In addition to its role in cell transformation mediated by the small DNA tumour viruses, overexpression of PP2A c has been shown to reduce HA-ras-induced cellular transformation [250] . Disturbance of PP2A has also been implicated in other virus-related phenomena. By increasing the ratio of PP2A D over holoenzyme, HIV-1 transcription and virus production was inhibited [243] . The HIV-1-encoded protein vpr has been shown to mediate a G # arrest through a specific interaction with B\PR55, targeting the complex to the nucleus and leading to dephosphorylation of Cdc25 [245] . The complex of vpr with the HIV-1-encoded nucleocapsid protein (NCp7) stimulated PP2A in itro, more than did both proteins separately, probably acting as polycations [244] . The adenovirus type 5 seems to induce apoptosis through a direct and specific interaction of the adenovirus E4orf4 protein with B\PR55α [246] [247] [248] [249] .
PP2A and (viral) DNA replication
One of the essential functions of the SV40 large T antigen is the initiation of viral DNA replication. To achieve this goal, it possesses site-specific DNA binding, ATPase and DNA unwinding (or helicase) activities. Large T is phosphorylated at multiple Ser and Thr sites (reviewed in [251] ), which play a role in its regulation. Inhibition of large T dephosphorylation by addition of low concentrations of OA substantially inhibits SV40 DNA replication in itro [252] . Addition of purified PP2A C to a cell-free SV40 replication system stimulates DNA replication by direct dephosphorylation of the inhibitory Ser"#!, Ser"#$, Ser('( and Ser'(* sites of large T [253, 254] . SV40 small t inhibits the PP2A-mediated dephosphorylation of the large T inhibitory sites, suggesting that it maintains large T in an inactive state until its activation at an appropriate point in the cycle [255] . In addition to free PP2A C , the trimeric ACBd\PR72 [63] and ABhC complexes [48] can also dephosphorylate the inhibitory Ser"#! and Ser"#$ residues and stimulate large-T-dependent origin unwinding. In contrast, PP2A D and trimeric ABC actively inhibit large T function by dephosphorylating the stimulatory p34 cdc# target site, Thr"#% [63] . As such, dephosphorylation of large T by PP2A constitutes a nice example of the substrate specificity of different PP2A holoenzyme complexes.
More recently, a role was also described for PP2A in the replication of chromosomal DNA. Immunodepletion of PP2A from a cell-free Xenopus egg extract resulted in a strong inhibition of DNA replication, due to the inhibition of DNA replication initiation, but not elongation [256] . The newly discovered Bd\PR48 subunit may mediate these effects of PP2A, since it interacts with Cdc6, a protein required for the initiation of DNA replication [56] .
PP2A and signal transduction
Eukaryotic cells can adjust their metabolism, growth and differentiation in response to extracellular signals via complex networks of reversible phosphorylation. In classical models of regulation by reversible phosphorylation, PPases reverse the effects of protein kinases by dephosphorylating the substrates of these kinases. However, a lot of data have emerged indicating that one of the major classes of phosphatase substrates is in fact the kinases themselves, the activity of which -in many cases -is negatively regulated by dephosphorylation. Conversely, the activity of the PPases can be regulated by kinases as well. In the case of PP2A, these phosphorylations affect its activity negatively.
PP2A as a kinase phosphatase
PP2A can modulate the activities of several kinases in itro and in i o, in particular phosphorylase kinase [257] , the ERK\ MAPKs, the calmodulin-dependent kinases, PKA, protein kinase B (PKB), PKC, p70 S' kinase, the IκB kinases (where IκB is inhibitor of nuclear factor-κB) and the Cdks (reviewed in [258] ).
The major PKA PPase activity in cell extracts is PP2A-like [259] . PKB is inactivated in itro by PP2A and is stimulated in cells upon treatment with OA [260] and calyculin A [261] . PP2A also mediates the dephosphorylation and inactivation of PKBα promoted by hyperosmotic stress [261] . A PP2A trimer containing B\PR55 inactivates PKCα in itro [262] , and in cell extracts the PPase responsible for PKCα dephosphorylation was identified as a membrane-bound, B\PR55-containing PP2A trimer [263] . In itro, PP2A can dephosphorylate and inactivate MEK1 and ERK-family kinases [264] [265] [266] , and both kinases are activated after treatment of cells with OA [267, 268] . As mentioned above, SV40 small t activates MEK1 and ERK [229] , and genetic evidence implicates PP2A in the Ras\MAPK pathway during photoreceptor development in Drosophila [205] and during vulval induction in Caenorhabditis elegans [269] . A major ERK PPase in extracts from PC12 cells is attributable to PP2A and an as yet unidentified PTPase [270] . IκB, an inhibitory subunit of NF-κB that is proteolytically degraded upon phosphorylation, becomes phosphorylated by a cytokine-regulated IκB kinase complex that contains two kinases, IKKα and IKKβ. IKKα is activated upon exposure of cells to OA and is inactivated by PP2A in itro [271] .
Direct interaction of PP2A with protein kinases : the concept of signalling modules
Very recent evidence has demonstrated the existence of another molecular device for the feedback regulation of signalling pathways, the so-called signalling modules. In these supramolecular structures, a kinase, which itself is regulated by phosphorylation, interacts directly with a phosphatase, for which it can become a substrate (or vice versa). As such, kinases and phosphatases can regulate their own activities (feedback) within a self-correcting signalling complex. For instance, protein kinase CKIIα (formerly known as casein kinase IIα) interacts with PP2A D via the C subunit in quiescent cells, and stimulates PP2A C activity towards Raf-phosphorylated MEK1 [272] . Expression of activated Raf results in disruption of the CKIIα-PP2A association [273] , which may be a necessary step for maximal activation of the MAPK pathway by Raf. Another signalling complex was identified in T lymphocytes between Ca# + \calmodulin-dependent kinase IV and PP2A [274] . PP2A dephosphorylates and inactivates this kinase, as measured by decreased transcriptional activity of CREB, even in the presence of high Ca# + concentrations. In rat brain extracts, PP2A was found in complexes with p70 S' kinase [275, 276] and with the p21-activated kinases PAK1 and PAK3 [275] . In itro, p70 S' kinase is inactivated by purified PP2A [277] . A sixth PP2A-interacting kinase is the Janus kinase JAK2, which associates transiently with PP2A upon interleukin-11 stimulation of adipocytes [278] . In L6 muscle cells, PP2A is associated with JAK2 in the basal state and upon insulin stimulation of the cells. Apparently, insulin inhibits PP2A activity by increasing tyrosine phosphorylation of PP2A C via JAK2 [75] .
Implication of PP2A in other signalling complexes
In the sarcoplasmic reticulum of cardiac muscle cells, PP2A has been found in a macromolecular complex together with the ryanodine receptor calcium release channel, the FK506 binding protein FKBP12.6, PKA, PP-1 and the anchoring protein muscle A-kinase anchor protein (AKAP), where it is probably involved in the regulation of channel activity [279] . PP2A (PP2A C , PR65 and probably a Bh\PR61 subunit) is also present in immunoprecipitates of rat forebrain class C L-type calcium channels, where it is able to reverse channel phosphorylation by AKAP-anchored PKA [280] . Another scaffolding protein, termed CG-NAP (centrosome-and Golgi-localized PKN-associated Structure, function and regulation of protein phosphatase 2A
protein) was found to bind PP2A C through the Bd\PR130 subunit [281] . PP-1 C , the regulatory R II subunit of PKA and the PKClike PKN kinase were identified as other members of the complex. CG-NAP is localized to centrosomes throughout the cell cycle and to the Golgi apparatus during interphase, suggesting that it may serve a targeting function for the associated kinases and phosphatases. Finally, in quiescent macrophages as well as those treated with colony-stimulating factor-1, PP2A C and PR65 were found in a large complex with the Raf-1 kinase, where they apparently serve to facilitate Raf-1 activation [282] .
The identification of other PP2A-interacting proteins defines roles for PP2A in translation, apoptosis and stress responses PP2A and the initiation of translation : Tap42/α4 and the TOR pathway
The TAP42 (two A phosphatase-associated protein) gene of Sacch. cere isiae was isolated as a multi-copy suppressor of SIT4 deficiency, and encodes a dimerization partner of both SIT4 (suppressor of His4 transcription 4) and PPH21\22 [283] . Interestingly, PP2A C can bind Tap42 directly, independently of the A and B subunits. Tap42-associated PP2A C accounts for about 2 % of the total cellular PP2A. The Tap42-PP2A and Tap42-SIT4 complexes are disrupted upon nutrient deprivation or treatment of the cells with the immunosuppressant rapamycin, leading to inhibition of the TOR pathway [283] . In Sacch. cere isiae, TOR, a protein kinase related to phosphatidylinositol 3-kinase and DNA-dependent protein kinase, functions in a pathway that connects nutrient stimulation to the initiation of protein synthesis. Rapamycin binds to the cyclophilin FKBP (FK506 binding protein), and the resulting complex specifically inhibits TOR function. The effect of rapamycin and starvation on the Tap42-PPase complexes therefore suggests that formation of these complexes necessitates TOR activity (or vice versa), and thus implicates Tap42, SIT4 and PP2A in the TOR pathway [283] . The mouse homologue of Tap42, α4, was originally discovered by its association with Ig-α, a component of the B-cell receptor complex IgR [284] . Upon stimulation of the receptor, α4 becomes phosphorylated, suggesting that it may be implicated in receptorinitiated signalling [285] . Like Tap42, α4 was found to bind to PP2A C , independently of the A and B subunits [286, 287] . The PP2A C -α4 complex showed increased activity towards phosphorylase a, MAPK-phosphorylated myelin basic protein and histone H1. Again, rapamycin led to disruption of the complex, suggesting the involvement of mTOR, the mammalian homologue of yeast TOR [286, 287] . mTOR functions in a mitogen-inducible pathway and causes phosphorylation of the translation inhibitor 4E-BP1 (eukaryotic initiation factor 4E binding protein 1) and of the serine\threonine p70 S' kinase, leading eventually to phosphorylation of the 40 S ribosomal protein S6 and the initiation of translation (reviewed in [288] ). Interestingly, PP2A C can dephosphorylate mTOR-phosphorylated 4E-BP1 in itro, whereas the PP2A C -α4 complex cannot [289] . In this case, addition of rapamycin fails to dissociate the complex in itro and cannot restore PP2A activity [289] . This is in line with data from another group, describing a constitutive and rapamycin-insensitive association between α4 and PP2A C , and between α4 and two PP2A-related PPases, PP4 and PP6 (the SIT4 homologue), in mammalian cells [290] . This association was shown subsequently to be inhibitory for the catalyic activity of all three PPases towards p-nitrophenyl phosphate as a substrate [291] .
The determinants specifying the interaction between PP2A C and Tap42\α4 have been investigated further. First, it was shown in yeast that inactivation of Cdc55 or Tpd3 resulted in rapamycin resistance, correlating with an increased association between Tap42 and Pph21\22 [292] . Moreover, these authors showed that TOR can phosphorylate Tap42 in itro and in i o, and that inactivation of Cdc55 or Tpd3 enhances the phosphorylation of Tap42 in i o. Thus TOR-phosphorylated Tap42 seems to compete effectively with Cdc55\Tpd3 for binding to PP2A C . Furthermore, Cdc55 and Tpd3 promote the direct dephosphorylation of Tap42, indicating that they inhibit association of Tap42 with PP2A C not only by direct competition with Tap42, but also by direct dephosphorylation of Tap42. Further, it was shown that mutation of both Tyr$!( and Leu$!* of PP2A C favours the association with α4, whereas the single mutations preferentially result in complex-formation with A\PR65 and\or B\PR55 [293] . These data could indicate that modification of the PP2A C C-terminus by phosphorylation or methylation influences its interaction with subunits A and B and with α4. Moreover, these authors found that overexpression of α4 resulted in decreased phosphorylation of eukaryotic elongation factor 2, but did not affect phosphorylation of p70 S' kinase or of 4E-BP1, suggesting that elongation factor 2 may be a direct target of α4-PP2A C . A model integrating the previous observations and the involvement of PP2A in the TOR pathway is illustrated in Figure 4 .
Recently, an α4-related protein, termed α4-b and showing 66 % identity with α4, was identified [294] . α4-b is expressed selectively in brain and testis, and also binds to PP2A C . As such, α4 and α4-b may be members of a completely new PP2A subunit family that does not require the presence of the A subunit to bind to PP2A C .
PP2A and the termination of translation
In addition to its role in translation initiation, PP2A is also likely to be involved in the termination of translation through the interaction of PP2A C with a translation termination factor, eRF1 (eukaryotic release factor 1) [295] . eRF1, or its yeast homologue SUP45, co-operates with eRF3 (SUP35) to terminate protein synthesis in ribosomes by acting as polypeptide chain release factors [296] [297] [298] [299] . Interaction with eRF1 occurs via the PP2A C N-terminus, but no dramatic effects were observed on PP2A activity (or vice versa). However, upon transient overexpression of eRF1 in COS cells, the amount of PP2A associated with the polysomes increases significantly, suggesting that eRF1 recruits PP2A into polysomes and brings it in close contact with putative substrates among the components of the translational apparatus [295] .
PP2A and apoptosis
A role for PP2A in apoptosis (programmed cell death) is suggested by its interaction with caspase-3 [300] , Bcl2 [103, 301] and adenovirus E4orf4 protein [246] [247] [248] [249] . Together with caspase-1, caspase-3 is one of the key executioners of apoptosis, being responsible for the cleavage of some key enzymes involved in DNA repair, such as poly(ADP-ribose) polymerase and DNAdependent protein kinase. Another substrate seems to be A\PR65, which was identified as an interaction partner of caspase-3 in a yeast two-hybrid assay [300] . In Jurkat cells induced to undergo apoptosis, caspase-3 is activated and cleaves A\PR65, thereby increasing the activity of PP2A C , as measured by decreased phosphorylation of MAPK [300] . The activity of Bcl2, a potent anti-apoptotic protein, is regulated by phosphorylation on Ser(!. This phosphorylation is required for its apoptosis-suppressing ability and can be reversed by an OAsensitive PPase, which was identified as a form of PP2A [301] . Moreover, interleukin-3-or bryostatin 1-induced phosphorylation of Bcl2 is followed rapidly by increased association between Bcl2 and PP2A C , prior to dephosphorylation of Bcl2 [301] .
Figure 4 Model implicating PP2A in the TOR pathway
Upstream activators of TOR in mammalian cells are not indicated, but include phosphatidylinositol 3-kinase, phosphoinositide-dependent kinase 1 and protein kinase B [288] . An additional downstream target of TOR is p70 S6 kinase, which, upon phosphorylation, becomes activated towards the ribosomal S6 protein, and as such contributes to the initiation of translation. It is noteworthy that Tap42/α4 can bind directly to PP2A C , independently of the A and B-type subunits. Abbreviations : FKBP, FK506 binding protein ; eEF, eukaryotic elongation factor ; eIF-4BP, eukaryotic initiation factor 4E binding protein.
Similar data were obtained in experiments using ceramide as the apoptotic inducer [103] . The adenovirus E4orf4 protein has many biological functions, including the induction of apoptosis in transformed cells. E4orf4 has been shown to interact with PP2A [246] , either through Bα or through some of the Bh subunits [247, 248] . However, for the induction of apoptosis, only the interaction with Bα is essential [248, 249] .
PP2A and the heat-shock response
One of the members of the family of heat-shock transcription factors, HSF2, which regulate the expression of the heat-shock protein (hsp) genes, has been shown to interact with A\PR65 [302] . This interaction blocks the association of A\PR65 with PP2A C and stimulates PP2A activity in cells. The ability of HSF2 to interfere with PP2A C binding to A\PR65 is due to its interaction with the critical Lys%"' residue [34] localized within HEAT repeat 11 of A\PR65 [303] . Further evidence for a role for PP2A in the heat-shock response comes from the observation that PP2A can dephosphorylate hsp27 (heat-shock protein 27) in itro and in interleukin-1β-or TNFα-treated MRC-5 cells in i o [304] . Tyrosine phosphorylation of PP2A C by pp60 c-src abolished PP2A activity towards phosphorylated hsp27, and may provide a mechanism for attenuation of the signal.
PP2A and the DNA-damage response Two-hybrid assays have indicated that the Bh\PR61α and Bh\PR61δ subunits of PP2A can associate with cyclin G [305] . Cyclin G is a p53-responsive gene product, which is induced upon activation of p53 by DNA-damaging agents [306] , and complex-formation between cyclin G and Bh\PR61 occurs only after induction of p53 [305] . The precise function of cyclin G has not yet been established, but it is known that it contributes to G # \M arrest of cells in response to DNA damage [307] , and in some cells it enhances the apoptotic response [308] . Immunolocalization studies in rat brain have indicated that the regional and subcellular localization of Bh\PR61α and Bh\PR61δ and of cyclin G are very similar at postnatal stages, but their developmental regulation differs [309] .
Overview
In summary, many proteins have been identified that interact with PP2A, each exhibiting its own specific effect. Some of them affect PP2A activity (such as I " PP#A , I # PP#A , PTPA, Tap42\α4, SV40 small t, polyoma middle T\small t, HIV-1 NCp7 :Vpr, adenovirus E4orf4, CKIIα, Hox11 and PKR), some are PP2A substrates (such as Bcl2, p70 S' kinase, Ca# + \calmodulin-dependent kinase IV, vimentin, paxillin and SCR), for some PP2A itself is a substrate (such as caspase-3, JAK2, PME-1 and PKR) and some act as targeting proteins (such as eRF1, axin, APC and CG-NAP). An overview is given in Figure 5 .
Other putative PP2A substrates : the Rb and p53 tumour suppressor proteins
Phosphorylation is one of the major mechanisms regulating p53 function in response to DNA-damaging agents. p53 is phosphorylated on multiple serine\threonine sites in itro and in i o (reviewed in [310] ). Some of these sites are important for tumour suppression, DNA binding or transactivation, whereas the function of others is currently unknown. In itro, p53 can be dephosphorylated by both PP-1 [311] and PP2A [255, 311, 312] . The latter is inhibited in itro by SV40 small t [255] . Treatment of cells with PP-1-and PP2A-specific inhibitors, including OA, results in the accumulation of hyperphosphorylated p53 [312] [313] [314] [315] . Transient expression of SV40 small t enhances p53 phosphorylation, DNA binding and transactivation activity, whereas OA additionally causes p53-dependent apoptosis [315] . On the other hand, there is some cross-talk between PP2A and p53, in the sense that p53 may also affect PP2A regulation Structure, function and regulation of protein phosphatase 2A
Figure 5 PP2A interacts with a variety of viral and cellular proteins through its A, B/Bh/Bd/Be or C subunits
These interacting partners serve as PP2A substrates (such as vimentin), act as targeting proteins (such as eRF1) or affect PP2A activity (such as the viral antigens). For PME-1, JAK2, PKR and caspase-3, PP2A itself is a substrate. Note that HSF2 and Tap42/α4 can interfere with PP2A C binding to A/PR65 by binding to the A and C subunits respectively. The still growing list of interacting proteins adds quite a level of complexity to the overall regulation of PP2A. Abbreviation : CaMKIV, Ca 2 + /calmodulin-dependent kinase IV.
through its effect on the expression of PTPA [132] and cyclin G [305, 306] . Rb is phosphorylated in a cell-cycle-dependent manner : in G ! or early G " , it is present as a hypophosphorylated protein, whereas in cells progressing towards S-phase it becomes hyperphosphorylated. At the end of M-phase, Rb is quickly dephosphorylated again. PP-1 is the major Rb phosphatase in i o [316] [317] [318] . However, specific inhibition of PP2A activity exhibits an indirect effect on Rb phosphorylation [319] . In this case, decreased Rb phosphorylation results from the suppression of G " Cdks (including Cdk2, Cdk4 and Cdk6), that normally phosphorylate Rb during G " . In other words, PP2A activity is crucial for the activation or maintenance of G " Cdk activity, implying a positive role for PP2A in the G " \S transition. On the other hand, the Rb-related p107 protein seems to be dephosphorylated directly by a PP2A PPase in response to UV irradiation [320] . Probably this effect is mediated by the Bd\PR59 subunit, which interacts directly with p107 [55] .
PP2A and pathologies
Tau and Alzheimer's disease
The high levels of expression of both PP2A C isoforms in brain [9] and the brain-specific expression of some members of the B\PR55 [35, 37, 39] and Bh\PR61 [44, 45] subunit families suggests that PP2A has unique functions in neuronal cells (reviewed in [321] ).
Within neurons, PP2A seems to be targeted to specific intracellular locations, such as the neurofilaments. Neurofilamentassociated PP2A dephosphorylates neurofilaments NF-M and NF-L [322, 323] . As phosphorylation controls assembly, neurofilament-associated PP2A probably regulates the stability of neurofilaments and\or their interactions with other components of the neuronal cytoskeleton.
Another potential function of PP2A in the brain is regulation of the phosphorylation state of microtubule-associated proteins. Neuronal-specific microtubule-associated proteins, including tau and MAP-2, bind to microtubules and regulate microtubule stability. They are phosphorylated at multiple sites by a variety of protein kinases, resulting in the dissociation of microtubuleassociated proteins from microtubules and loss of stability (reviewed in [324] ). Interestingly, the accumulation of hyperphosphorylated tau in neurofibrillary tangles is a pathological hallmark of Alzheimer's disease, and this hyperphosphorylation of tau has been proposed as a mechanism leading to neuronal degeneration, characteristic of this disease [325, 326] . As mentioned above, a pool of PP2A, composed mainly of ABαC, is associated with microtubules [183] . In a more recent report, it was shown that only trimeric PP2A forms containing B\PR55α or B\PR55β, but not B\PR55γ or Bh\PR61, associate with neuronal microtubules, and that this interaction depends on an as yet unidentified anchoring factor [327] . Moreover, PP2A can dephosphorylate specific sites of (hyper)phosphorylated tau in itro and in situ [328] [329] [330] [331] [332] [333] . Co-expression of SV40 small t leads to hyperphosphorylation of tau, accompanied by dissociation of tau from the microtubules and loss of microtubule bundles [334] . Similar effects are observed upon treatment of neuronal cells with PP2A-selective concentrations of OA [335] . In addition, PP2A interacts directly with soluble tau and targets it for dephosphorylation [334] . The identification of the structural interactions between tau, PP2A and microtubules has revealed that PP2A binds tau and microtubules through distinct sites, and therefore may be able to anchor tau to the microtubules [336] . Moreover, these authors suggest that PP2A activity towards tau can be modulated by microtubule dynamics. Thus disruption of the normal interactions among PP2A, tau and the microtubules may contribute to the development of tauopathies, such as Alzheimer's disease.
PP2A and carcinogenesis
Initial evidence for a negative role for PP2A in carcinogenesis came from the observation that the tumour promoter OA [148] is a potent inhibitor of PP2A [136] . More recently, cytostatin, an inhibitor of cell adhesion and a powerful anti-metastatic drug, was also demonstrated to inhibit PP2A selectively [337] . Additionally, the PR65α and PR65β subunits have been identified as tumour suppressors, their genes being mutated in melanomas, lung and breast carcinomas for PR65α [29] , and in 15 % of primary lung and colon tumour-derived cell lines for PR65β [27] . Moreover, de-regulation (overexpression) of PR61γ in malignant melanoma, as compared with normal epidermal melanocytes, reveals a role for PP2A in melanoma tumour progression [338] .
More recently, a retrotransposon insertion in the gene encoding PR61γ1, causing the expression of an N-terminally truncated form of PR61γ1, was associated with a higher metastatic state of melanoma cells [339] . This increase in cell migration was linked to increased paxillin phosphorylation at the focal adhesions. Apparently, PR61γ1 interacts specifically with paxillin and thereby targets PP2A to the focal adhesions, where it then acts to dephosphorylate paxillin. The N-terminally truncated PR61γ1 did not lose this targeting ability, but the resulting PP2A trimer failed to dephosphorylate paxillin, resulting in enhanced cell spreading [339] . Also, in some human leukaemias, normal PP2A regulation is disturbed, due to certain chromosomal translocations resulting in the formation of SET-CAN and HRX fusion proteins (see above) [112, 113] . In addition, PP2A inhibits nuclear telomerase activity in human breast cancer cells [340] . In normal somatic cells, telomerase activity is below detectable levels, but in most primary human malignancies it is elevated by an as yet unknown mechanism, suggesting that de no o synthesis of telomeres is crucial for unlimited cell division. By inhibiting this enhanced telomerase activity in cancer cells, PP2A can therefore counteract uncontrolled cell growth.
CONCLUSIONS AND PERSPECTIVES
The pivotal role of PP2A in such a variety of cellular processes simply necessitates proper regulation of enzyme activity and localization. We now have an outline of how these regulatory mechanisms operate, but many challenges remain. One of the central quests in the field is elucidating the dynamics of all observed PP2A interactions, and how they react to extracellular and internal signals that contribute to the overall response of a particular cell. While the role of PP2A C carboxymethylation appears to be vital for proper PP2A functioning in i o, the regulation of methylesterase and methyltransferase activities remains elusive. Also, the role of PTPA as a putative PP2A C ' chaperone ' should be clarified further. Additional data on the specific functions of the B-type subunits and the cellular processes in which they are involved may emerge from knock-out studies in mice, or, given the many genome projects at hand, from genetic studies in other eukaryotes such as Drosophila and Caenorhabditis. It may be hoped that these studies may eventually lead to the discovery of therapeutic agents that can counteract PP2A de-regulation in some cancers or virally transformed cells. 
